FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations

Understanding disease pathology often does not require an overall proteomic analysis of clinical samples but rather the analysis of different, often rare, subpopulations of cells in a heterogeneous mixture of cell types. For the isolation of pre-specified cellular subtypes, fluorescence activated ce...

Full description

Bibliographic Details
Main Authors: Evelyne Maes, Nathalie Cools, Hanny Willems, Geert Baggerman
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/18/6557
id doaj-2c06fa4c96044c6f9d087c50d4140600
record_format Article
spelling doaj-2c06fa4c96044c6f9d087c50d41406002020-11-25T03:47:07ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-09-01216557655710.3390/ijms21186557FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell PopulationsEvelyne Maes0Nathalie Cools1Hanny Willems2Geert Baggerman3Food & Bio-Based Products, AgResearch Ltd., Lincoln 7674, New ZealandLaboratory of Experimental Hematology, Faculty of Medicine and Health Sciences, Vaccine and Infectious Disease Institute (VaxInfectio), Antwerp University Hospital (UZA), University of Antwerp, 2020 Antwerpen, BelgiumCentre for Proteomics, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerpen, BelgiumCentre for Proteomics, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerpen, BelgiumUnderstanding disease pathology often does not require an overall proteomic analysis of clinical samples but rather the analysis of different, often rare, subpopulations of cells in a heterogeneous mixture of cell types. For the isolation of pre-specified cellular subtypes, fluorescence activated cell sorting (FACS) is commonly used for its ability to isolate the required cell populations with high purity, even of scarce cell types. The proteomic analysis of a limited number of FACS-sorted cells, however, is very challenging as both sample preparation inefficiencies and limits in terms of instrument sensitivity are present. In this study, we used CD14+CD15+ immune cells sorted out of peripheral blood mononuclear cells isolated from whole blood to improve and evaluate FACS-based proteomics. To optimize both the protein extraction protocol and the mass spectrometry (MS) data acquisition method, PBMCs as well as commercialized HeLa digest were used. To reflect the limited number of sorted cells in some clinical samples, different numbers of sorted cells (1000, 5000, 10,000, or 50,000) were used. This allowed comparing protein profiles across samples with limited protein material and provided further insights in the benefits and limitations of using a very limited numbers of cells.https://www.mdpi.com/1422-0067/21/18/6557FACSproteomicscellular heterogeneity
collection DOAJ
language English
format Article
sources DOAJ
author Evelyne Maes
Nathalie Cools
Hanny Willems
Geert Baggerman
spellingShingle Evelyne Maes
Nathalie Cools
Hanny Willems
Geert Baggerman
FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
International Journal of Molecular Sciences
FACS
proteomics
cellular heterogeneity
author_facet Evelyne Maes
Nathalie Cools
Hanny Willems
Geert Baggerman
author_sort Evelyne Maes
title FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
title_short FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
title_full FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
title_fullStr FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
title_full_unstemmed FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations
title_sort facs-based proteomics enables profiling of proteins in rare cell populations
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-09-01
description Understanding disease pathology often does not require an overall proteomic analysis of clinical samples but rather the analysis of different, often rare, subpopulations of cells in a heterogeneous mixture of cell types. For the isolation of pre-specified cellular subtypes, fluorescence activated cell sorting (FACS) is commonly used for its ability to isolate the required cell populations with high purity, even of scarce cell types. The proteomic analysis of a limited number of FACS-sorted cells, however, is very challenging as both sample preparation inefficiencies and limits in terms of instrument sensitivity are present. In this study, we used CD14+CD15+ immune cells sorted out of peripheral blood mononuclear cells isolated from whole blood to improve and evaluate FACS-based proteomics. To optimize both the protein extraction protocol and the mass spectrometry (MS) data acquisition method, PBMCs as well as commercialized HeLa digest were used. To reflect the limited number of sorted cells in some clinical samples, different numbers of sorted cells (1000, 5000, 10,000, or 50,000) were used. This allowed comparing protein profiles across samples with limited protein material and provided further insights in the benefits and limitations of using a very limited numbers of cells.
topic FACS
proteomics
cellular heterogeneity
url https://www.mdpi.com/1422-0067/21/18/6557
work_keys_str_mv AT evelynemaes facsbasedproteomicsenablesprofilingofproteinsinrarecellpopulations
AT nathaliecools facsbasedproteomicsenablesprofilingofproteinsinrarecellpopulations
AT hannywillems facsbasedproteomicsenablesprofilingofproteinsinrarecellpopulations
AT geertbaggerman facsbasedproteomicsenablesprofilingofproteinsinrarecellpopulations
_version_ 1724503311413936128